Cargando…
Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746276/ https://www.ncbi.nlm.nih.gov/pubmed/36629242 http://dx.doi.org/10.4103/lungindia.lungindia_355_22 |
| _version_ | 1784849327046262784 |
|---|---|
| author | Udwadia, Zarir F. Pawar, Unmesha Prakash Nanda, Viral Jayshinh |
| author_facet | Udwadia, Zarir F. Pawar, Unmesha Prakash Nanda, Viral Jayshinh |
| author_sort | Udwadia, Zarir F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9746276 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97462762022-12-14 Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy Udwadia, Zarir F. Pawar, Unmesha Prakash Nanda, Viral Jayshinh Lung India Research Letters Wolters Kluwer - Medknow 2022 2022-10-25 /pmc/articles/PMC9746276/ /pubmed/36629242 http://dx.doi.org/10.4103/lungindia.lungindia_355_22 Text en Copyright: © 2022 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Research Letters Udwadia, Zarir F. Pawar, Unmesha Prakash Nanda, Viral Jayshinh Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title | Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title_full | Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title_fullStr | Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title_full_unstemmed | Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title_short | Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy |
| title_sort | severe interstitial lung disease persisting 2 years post-covid-19 despite anti-fibrotic therapy |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746276/ https://www.ncbi.nlm.nih.gov/pubmed/36629242 http://dx.doi.org/10.4103/lungindia.lungindia_355_22 |
| work_keys_str_mv | AT udwadiazarirf severeinterstitiallungdiseasepersisting2yearspostcovid19despiteantifibrotictherapy AT pawarunmeshaprakash severeinterstitiallungdiseasepersisting2yearspostcovid19despiteantifibrotictherapy AT nandaviraljayshinh severeinterstitiallungdiseasepersisting2yearspostcovid19despiteantifibrotictherapy |